Skip to main content

Table 1 Patients and cycle characteristics

From: Letrozole-associated controlled ovarian hyperstimulation in breast cancer patients versus conventional controlled ovarian hyperstimulation in infertile patients: assessment of oocyte quality related biomarkers

 

Study group

Control Group

P value

N patients

23

24

 

N cycles

27

24

 

Age (years)

30.4 ± 3.8

30.8 ± 3.9

0.71

AMH (ng/dl)

2.7 ± 2.1

3.1 ± 1.7

0.32

N stimulation days

9.9 ± 2.6

9.7 ± 1.3

0.8

Total dose of FSH used

2280 ± 1027

1629 ± 624

0.004

E2 level at triggering (pg/ml)

315 ± 225

2144 ± 915

< 0.001

Triggering methods (cycles)

  

0.22

hCG

9

12

 

GnRHa

18

12

 

Number of oocytes collected

9.5 ± 5.1

10.9 ± 6.8

0.4

Maturation rate

0.83 ± 0.19

0.87 ± 0.14

0.34

Back to article page

Reproductive Biology and Endocrinology

ISSN: 1477-7827

Contact us